Arbaclofen has been researched along with sk&f 97541 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, PA; Brugger, F; Froestl, W; Gentsch, C; Hall, RG; Jaekel, J; Mickel, SJ; Olpe, HR; Strub, D; von Sprecher, G | 1 |
| Annamalai, T; Chen, JL; Chernov-Rogan, T; Dilip, U; Gallop, MA; Grindstaff, K; Koller, K; Peng, G; Phan, T; Wustrow, DJ; Xu, F; Zhang, X | 1 |
2 other study(ies) available for Arbaclofen and sk&f 97541
| Article | Year |
|---|---|
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
Topics: Animals; Behavior, Animal; Cats; Crystallography, X-Ray; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Organophosphonates; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Stereoisomerism; Structure-Activity Relationship | 1995 |
Discovery of a novel potent GABA(B) receptor agonist.
Topics: Animals; Baclofen; Blood-Brain Barrier; Drug Discovery; GABA Agonists; Humans; Mice; Receptors, GABA-B | 2011 |